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An Outbreak of Hemolytic Uremic
Syndrome due to Escherichia coli
O157:H-: Or Was It?
To the Editor: Since the first reported out-
breaks of hemolytic uremic syndrome (HUS) and
related conditions more than 10 years ago (1),
outbreaks of HUS due to Escherichia coli O157
have been reported from many parts of the world,
particularly North America and Europe. While
mostofthesereportshaveincriminatedthemotile
strains of serotype O157:H7, nonmotile serotypes
(e.g., O157:H-) have also been associated with
HUS; these two serotypes are most commonly
associatedwithbothoutbreaksandsporadiccases
of HUS and related conditions. Over the last dec-
ade, a number of techniques for the rapid identifi-
cation of these organisms have been developed.Of
these, the use of sorbitol-MacConkey agar (2) has
perhaps been the most valuable.This technique is
based on the fact that these organisms rarely
ferment sorbitol on primary isolation, while most
other E. coli usually ferment this substrate. We
believe that outbreaks due to other enterohemor-
rhagic E. coli may have been attributed to sero-
groupO157becauseofthelimitedtechnologyused
in investigating these outbreaks.
No outbreaks of HUS due to serogroup O157
have occurred in Australia despite sporadic cases
of HUS caused by such strains. Other serogroups
(particularly serotype O111:H-) have been associ-
ated with most cases of HUS and related condi-
tions in Australia (3). No outbreak of HUS had
been reported in Australia until January 1995,
when an outbreak associated with the consump-
tion of contaminated mettwurst (fermented sau-
sage) was reported from South Australia (4).
Twenty-three children with HUS were hospital-
ized. Most required hemodialysis; one died. Vero-
cytotoxigenic strains of E. coli O111 producing
Shiga-like toxin (SLT) I and II were isolated from
19 patients and from samples of mettwurst. In
addition,strains of E.coli O157:H- that produced
SLT-I and SLT-II were isolated from three of the
patients and the mettwurst.These strains did not
ferment sorbitol on the sorbitol-MacConkey agar,
which facilitated their isolation.The predominant
O111 strains were sorbitol-positive, unlike the
O111 strains,recently described as being sorbitol-
negative(5).Symptomsofthepatientsfromwhom
the O157:H- strains were isolated, in addition to
E. coli O111:H-, were not significantly different
from those of the patients whose specimens
yielded only E. coli O111:H-. In addition to O111
(and O157),other serotypes of enterohemorrhagic
E. coli, including strains of serogroup O23, O26,
and O91, were isolated from the patients. How-
ever, antibodies to O111 were detected in nearly
all patients, which indicates the serogroup’s lead-
ingroleintheoutbreak.Theisolationofserogroup
O157 is comparatively easy; therefore, it is less
likely that these strains would have been missed,
than it is that O111 and other serotypes would
have been. Even though a negative finding can
never be considered conclusive, we consider the
inability to isolate serogroup O157 more conclu-
sive than the same result for other serotypes. It
has frequently been suggested that the O157 se-
rogroup is cleared from the patient relatively rap-
idly, which makes its isolation difficult or
impossible. We found a similar situation with
other enterohemorrhagic E. coli serotypes. The
fact that most patients elicited an O111 antibody
response (and no anti-O157) almost certainly
proves this serotype’s causal role in this outbreak.
The laboratory in South Australia was particu-
larly well disposed to deal with such an outbreak
because some of its ongoing research programs
included studies on aspects of enterohemorrhagic
E. coli and related organisms. The most sophisti-
cated molecular biologic techniques were immedi-
ately available to investigate the outbreak
accurately and confirm epidemiologic leads re-
garding a common source.Polymerase chain reac-
tion (PCR) played a major role not only in
identifying SLT-I, SLT-II, and SLT-I and SLT-II
producingbacteriainthestoolofpatients,butalso
in identifying the suspected source (mettwurst).
In addition, PCR, utilizing sequences specific for
the O111 serogroup, enabled this serogroup to be
rapidly identified in patients’ feces samples and
suspected source material. Without this technol-
ogy, the outbreak would not have been contained
sorapidly.Ontheotherhand,ifthelaboratoryhad
to rely on conventional microbiologic culture pro-
cedures, including sorbitol-MacConkey agar,
strains of serogroup O157 would have been iden-
tified from three patients, as well as from the
epidemiologically incriminated mettwurst. The
laboratory would not have found the O111 strains
because they all fermented sorbitol readily and
would have been discarded as normal flora as
would the other enterohemorrhagic E. coli sero-
types. The outbreak would have been reported as
another O157 outbreak, from which only about
15% of the patients yielded the incriminating
strains. This outbreak could be recognized as one
caused by a number of different enterohemor-
rhagic E. coli serotypes, of which serotypes
O111:H- and O157:H- were the most prominent.
Letters
Vol. 2, No. 2— April-June 1996 153 Emerging Infectious DiseasesOther serotypes, however, such as O23, O26, and
O91, were also present. With the widespread na-
ture of verocytotoxigenic strain of different sero-
types as has been reported from many
environmental studies, it is not surprising that a
product, such as mettwurst, which is made from
meats from various sources, would contain a
number of these potential pathogens.
A large number of E. coli serotypes can be
verocytotoxigenic and, in a few cases, outbreaks
due to such strains have been reported. Most no-
table have been reports from Italy of outbreaks
due to enterohemorrhagic E. coli O111 (6); how-
ever,theimpressionisthatthesearetheexception
andthatthemostprominentserotypeisO157:H7.
Some of the reported outbreaks due to O157
strains may in fact have been due to other sero-
types and the O157 strains were only present in
comparatively small numbers; however, because
of the ease with which these strains can be iden-
tified using sorbitol-MacConkey agar, they were
believed responsible for the outbreaks. For exam-
ple, in Argentina, E. coli O157:H7 was found in
only one (2%) of 51 children with HUS (7) and in
the Netherlands, only 5 (19%) of 26 HUS patients
yieldedE.coliO157:H7(8).Ina10-year,retrospec-
tive,population-based study of HUS,this serotype
was isolated in 13 (46%) of 28 patients (9), and in
their review, Su and Brandt (10) put an overall
figure of 46% to 58% as the incidence range of E.
coli O157:H7 infection in cases of HUS. Finding
SLT sequences in a fecal specimen by PCR,or free
fecal toxins in many patients of an outbreak while
isolating strains of O157 from only a few, does not
exclude the presence of other serotypes, but cul-
ture methods now available would rarely pick
these up. Thus there is ample room to speculate
that approximately half the cases of HUS may be
caused by serogroups other than O157 and, by
inference, at least half the outbreaks may be
wronglyattributedtothisserogroup.Werecognize
that enterohemorrhagic E.coli O157 have become
extraordinarily widespread throughout the world
since their first description (1);this does not mean
that other serotypes are not also causing infec-
tions, either alone, in conjunction with O157, or
even with other known or unknown enteric infec-
tions. It is important to be aware of the existence
of these other serotypes and be vigilant for them.
The isolation and characterization of strains of
serogroup O157 from patients with HUS is cer-
tainly noteworthy, but so is the finding of O111 or
any other serogroup. Serogroup O111 has amply
demonstrated the ability to cause extensive
outbreaks (6).Even though many laboratories are
becoming aware of the importance of testing for
serogroup O157:H7, we think that testing for this
serotype only is a disservice; simple culture tech-
niques can identify this serogroup, but always at
the risk of missing other serogroups.The develop-
ment of simple methods to detect all enterohem-
orrhagic E. coli is now required.
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